IVONESCIMAB
Clinical trials for IVONESCIMAB explained in plain language.
Never miss a new study
Get alerted when new IVONESCIMAB trials appear
Sign up with your email to follow new studies for IVONESCIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: ivonescimab trial launches
Disease control Recruiting nowThis Phase 2 trial tests the drug ivonescimab in 40 people with advanced clear cell renal cell carcinoma that has worsened after prior treatment. The goal is to see if the drug can help control the cancer and to monitor any side effects. Participants receive ivonescimab by IV inf…
Matched conditions: IVONESCIMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study tests a combination of an immunotherapy drug (ivonescimab) with two chemotherapy drugs before surgery for people with a certain type of advanced esophageal cancer. The goal is to see if this approach can shrink tumors enough to improve long-term outcomes. About 45 adul…
Matched conditions: IVONESCIMAB
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC